Free Trial

LENZ Therapeutics (LENZ) News Today

LENZ Therapeutics logo
$33.91 -0.74 (-2.14%)
(As of 11/20/2024 ET)
LENZ Therapeutics, Inc. stock logo
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Buy" by Analysts
Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) have been given an average recommendation of "Buy" by the seven analysts that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy rating and one has given a strong buy rating t
LENZ Therapeutics, Inc. stock logo
LENZ Therapeutics (NASDAQ:LENZ) Shares Down 6.3% - Here's Why
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 6.3% - What's Next?
HC Wainwright Expects Higher Earnings for LENZ Therapeutics
LENZ Therapeutics, Inc. stock logo
LENZ Therapeutics (NASDAQ:LENZ) Hits New 1-Year High - What's Next?
LENZ Therapeutics (NASDAQ:LENZ) Reaches New 1-Year High - Here's What Happened
William Blair Has Optimistic Outlook of LENZ FY2024 Earnings
LENZ Therapeutics, Inc. stock logo
Leerink Partnrs Brokers Boost Earnings Estimates for LENZ
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Equities researchers at Leerink Partnrs raised their Q4 2024 earnings per share estimates for LENZ Therapeutics in a report released on Wednesday, November 6th. Leerink Partnrs analyst M. Goodman now forecasts that the company will post earnin
LENZ Therapeutics, Inc. stock logo
HC Wainwright Has Positive Forecast for LENZ FY2024 Earnings
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Stock analysts at HC Wainwright raised their FY2024 earnings per share (EPS) estimates for LENZ Therapeutics in a research note issued to investors on Thursday, November 7th. HC Wainwright analyst M. Caufield now anticipates that the company w
LENZ Therapeutics, Inc. stock logo
FY2024 EPS Estimate for LENZ Therapeutics Boosted by Analyst
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Equities researchers at William Blair boosted their FY2024 earnings per share (EPS) estimates for shares of LENZ Therapeutics in a report issued on Wednesday, November 6th. William Blair analyst L. Hanbury-Brown now expects that the company wi
LENZ Therapeutics Reports Third Quarter 2024 Financial Results
Lenz Therapeutics price target raised to $36 from $32 at Leerink
LENZ Therapeutics, Inc. stock logo
LENZ Therapeutics (LENZ) Set to Announce Earnings on Wednesday
LENZ Therapeutics (NASDAQ:LENZ) will be releasing earnings before the market opens on Wednesday, November 6, Zacks reports.
Leerink Partners Sticks to Its Buy Rating for LENZ Therapeutics (LENZ)
LENZ Therapeutics, Inc. stock logo
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Recommendation of "Buy" by Analysts
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has earned an average recommendation of "Buy" from the seven ratings firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has assigned a
Lenz Therapeutics announces FDA acceptance of NDA for LNZ100
FDA Accepts LENZ Therapeutics' NDA For LNZ100 To Treat Presbyopia
LENZ Therapeutics, Inc. stock logo
FY2028 Earnings Forecast for LENZ Issued By Leerink Partnrs
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Equities researchers at Leerink Partnrs upped their FY2028 earnings per share estimates for shares of LENZ Therapeutics in a research note issued to investors on Tuesday, October 15th. Leerink Partnrs analyst M. Goodman now expects that the co
LENZ Therapeutics, Inc. stock logo
Marshall Wace LLP Makes New $390,000 Investment in LENZ Therapeutics, Inc. (NASDAQ:LENZ)
Marshall Wace LLP purchased a new stake in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 22,554 shares of the company's stock, valued at a
LENZ Therapeutics, Inc. stock logo
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Recommendation of "Buy" by Brokerages
Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) have earned a consensus recommendation of "Buy" from the seven analysts that are presently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a buy rating and one has given a strong buy rating
LENZ Therapeutics, Inc. stock logo
LENZ Therapeutics (NASDAQ:LENZ) Now Covered by Analysts at Raymond James
Raymond James initiated coverage on LENZ Therapeutics in a research report on Friday. They set an "outperform" rating and a $37.00 price target for the company.
LENZ Therapeutics, Inc. stock logo
Bank of New York Mellon Corp Buys 28,556 Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ)
Bank of New York Mellon Corp raised its stake in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) by 255.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,737 shares of the comp
LENZ Therapeutics, Inc. stock logo
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Up 7.8%
LENZ Therapeutics (NASDAQ:LENZ) Shares Up 7.8%
LENZ Therapeutics, Inc. stock logo
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Average Recommendation of "Buy" from Analysts
Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) have received a consensus rating of "Buy" from the six brokerages that are covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month target price am
LENZ Therapeutics, Inc. stock logo
Wealth Enhancement Advisory Services LLC Takes $1.44 Million Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)
Wealth Enhancement Advisory Services LLC acquired a new position in LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 83,103 shares of the company's
LENZ Therapeutics, Inc. stock logo
Vanguard Group Inc. Purchases Shares of 206,952 LENZ Therapeutics, Inc. (NASDAQ:LENZ)
Vanguard Group Inc. acquired a new stake in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 206,952 shares of the company's stock, valued at approx
LENZ Therapeutics, Inc. stock logo
HC Wainwright Equities Analysts Reduce Earnings Estimates for LENZ Therapeutics, Inc. (NASDAQ:LENZ)
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Equities researchers at HC Wainwright decreased their FY2028 earnings estimates for shares of LENZ Therapeutics in a research report issued to clients and investors on Thursday, August 15th. HC Wainwright analyst M. Caufield now anticipates th
LENZ Therapeutics, Inc. stock logo
LENZ Therapeutics' (LENZ) Overweight Rating Reaffirmed at Piper Sandler
Piper Sandler reaffirmed an "overweight" rating and issued a $36.00 price target on shares of LENZ Therapeutics in a report on Thursday.
Get LENZ Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter.

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

Get Your Free Gold Guide

LENZ Media Mentions By Week

LENZ Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LENZ
News Sentiment

1.20

0.46

Average
Medical
News Sentiment

LENZ News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LENZ Articles
This Week

3

2

LENZ Articles
Average Week

Get LENZ Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LENZ) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners